MediXall (MDXL) Change in Accured Expenses (2019 - 2024)
MediXall's Change in Accured Expenses history spans 8 years, with the latest figure at $6223.0 for Q3 2024.
- For Q3 2024, Change in Accured Expenses fell 92.66% year-over-year to $6223.0; the TTM value through Sep 2024 reached $1.1 million, up 74.81%, while the annual FY2023 figure was $1.1 million, 101.6% up from the prior year.
- Change in Accured Expenses reached $6223.0 in Q3 2024 per MDXL's latest filing, down from $163748.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $767081.0 in Q4 2023 to a low of -$327761.0 in Q2 2021.
- Average Change in Accured Expenses over 5 years is $128708.7, with a median of $111800.0 recorded in 2021.
- Peak YoY movement for Change in Accured Expenses: tumbled 1832.21% in 2021, then skyrocketed 4833.02% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at $462807.0 in 2020, then tumbled by 75.84% to $111800.0 in 2021, then surged by 163.36% to $294440.0 in 2022, then skyrocketed by 160.52% to $767081.0 in 2023, then crashed by 99.19% to $6223.0 in 2024.
- Per Business Quant, the three most recent readings for MDXL's Change in Accured Expenses are $6223.0 (Q3 2024), $163748.0 (Q2 2024), and $182341.0 (Q1 2024).